SPI Extra
5.640,10
PKT
-2,07
PKT
-0,04
%
Werbung
Analysen zu SPI Extra-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.02.05 | Lonza Buy | Helvea | |
18.02.05 | Inficon Neutral | Helvea | |
17.02.05 | Kuros (Kuros Biosciences) Neutral | Helvea | |
16.02.05 | Lonza Buy | Helvea | |
16.02.05 | TX Group Neutral | Sarasin Research | |
14.02.05 | OC Oerlikon Reduce | Sarasin Research | |
14.02.05 | Swatch (I) Sector Outperform | Vontobel | |
15.02.05 | Swatch (I) Neutral | JP Morgan | |
11.02.05 | Valora Neutral | Sarasin Research | |
14.02.05 | Inficon Buy | Sarasin Research | |
10.02.05 | dormakaba Neutral | Sarasin Research | |
09.02.05 | Logitech Neutral | Sarasin Research | |
09.02.05 | Jungfraubahn Market Outperform | Vontobel | |
09.02.05 | Swatch (I) Buy | Sarasin Research | |
08.02.05 | Adecco SA Neutral | Sarasin Research | |
07.02.05 | Galenica Market Perform | Vontobel | |
04.02.05 | Clariant Neutral | HypoVereinsbank | |
07.02.05 | Sulzer Buy | Sarasin Research | |
04.02.05 | Swatch (N) Outperform | Goldman Sachs | |
07.02.05 | Basilea Pharmaceutica Outperform | Credit Suisse First Boston | |
03.02.05 | Komax Neutral | Sarasin Research | |
03.02.05 | Baloise Buy | Sarasin Research | |
04.02.05 | Komax Market Perform | Vontobel | |
03.02.05 | Rieter Neutral | Credit Suisse First Boston | |
03.02.05 | Swatch (I) Outperform | Goldman Sachs | |
03.02.05 | Rieter Neutral | Sarasin Research | |
02.02.05 | Swatch (I) Buy | Sarasin Research | |
02.02.05 | Rieter Neutral | Sarasin Research | |
01.02.05 | OC Oerlikon Reduce | Sarasin Research | |
01.02.05 | Logitech Kauf | SYZ & CO | |
01.02.05 | ARYZTA Buy | Helvea | |
31.01.05 | Vetropack A Market Perform | Vontobel | |
01.02.05 | Schindler Neutral | Helvea | |
31.01.05 | Lonza Reduce | Sarasin Research | |
31.01.05 | Kudelski Neutral | Sarasin Research | |
31.01.05 | Swatch (I) Buy | Sarasin Research | |
31.01.05 | Allreal Neutral | Credit Suisse First Boston | |
27.01.05 | Lonza Buy | Helvea | |
27.01.05 | Kudelski Buy | Helvea | |
28.01.05 | Swatch (I) Neutral | JP Morgan |